- Home
- PETS vs TVGN Comparison
PETS vs TVGN Comparison
Compare PETS & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$2.31
Company Overview
Basic Information| Metric | PETS | TVGN |
|---|---|---|
| Founded | 1996 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | Blank Checks |
| Sector | Consumer Staples | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6M | 63.9M |
| IPO Year | 2003 | N/A |
Fundamental Metrics
Financial Performance| Metric | PETS | TVGN |
|---|---|---|
| Price | $2.31 | $5.51 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $3.20 | N/A |
| AVG Volume (30 Days) | 88.1K | ★ 403.0K |
| Earning Date | 02-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $273,800,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.98 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.57 | $0.14 |
| 52 Week High | $4.32 | $10.76 |
Technical Indicators
Market Signals| Indicator | PETS | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 27.16 | 62.12 |
| Support Level | N/A | $0.53 |
| Resistance Level | $2.93 | $10.76 |
| Average True Range (ATR) | 0.12 | 0.97 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 8.25 | 46.78 |
Price Performance
Historical Comparison PETS
TVGN
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.